ArticleActa diabetologica2021

Reply to letter to the editor regarding "Use of DPP-4 inhibitors in patients with COVID-19".

Sebastiano Bruno Solerte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.